Search clinical trials for: HC-ER 20% Alcohol

Total 33 results

Zogenix, Inc.

Completed

A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)

Healthy
Zogenix, Inc.

Completed

A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

Postoperative Pain
Zogenix, Inc.

Completed

To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules

Healthy
Zogenix, Inc.

Completed

A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain

Osteoarthrosis
Zogenix, Inc.

Completed

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment

Renal Impairment
Zogenix, Inc.

Completed

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment

Hepatic Impairment
Boehringer Ingelheim

Completed

Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male Volunteers

Healthy
Impax Laboratories, LLC

Completed

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Multiple Sclerosis

United States, Canada, Estonia, Latvia, Ukraine
Polaris Group

Completed

PH 2 ADI-PEG 20 Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Taiwan
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke... and other collaborators

Terminated

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

United States, Taiwan, Germany, Belgium, United Kingdom
Carolyn Lauckner
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Not yet recruiting

TRAC-ER Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals (TRAC-ER)

HIV Infections | Risk Behavior | Alcohol Use Disorder

United States
University of Johannesburg

Completed

The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension

Essential Hypertension

South Africa
Rhodes Pharmaceuticals, L.P.

Completed

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD (PK003)

Attention-Deficit/Hyperactivity Disorder

United States
University of Utah
US Department of Veterans Affairs; U.S. Army Medical Research and Development...

Completed

Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2

Hyperhidrosis

United States
Bayer

Completed

Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily

Pain
Pfizer

Completed

Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation

Healthy

United States
Tris Pharma, Inc.
Premier Research Group plc

Completed

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

ADHD

United States
Medical Center Alkmaar
Aalborg University; VU University of Amsterdam; Technical University of Twente; Rudolf Magnus Institute - University of Utrecht and other collaborators

Completed

Evoked Fields After Median and Ulnar Stimulation

Complex Regional Pain Syndromes

Netherlands
Universidad de El Salvador

Terminated

Comparison of Two Preoperative Antiseptic Solutions Alcohol Based in Abdominal Elective Surgeries

Surgical Site Infection

El Salvador
Tris Pharma, Inc.
Massachusetts General Hospital; Massachusetts Institute of Technology

Completed

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
Pfizer

Completed

Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

Pain

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
Soroka University Medical Center

Unknown

Alcohol 20% for Separation of Pterygium and Comparison of Different Wound Closure Methods

Pterygium

Israel
Kowa Research Institute, Inc.

Completed

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

Healthy

United States
VA Office of Research and Development

Completed

Treatment Strategy for Alcohol Use Disorders in Veterans With TBI (AUD)

Alcohol Dependence

United States
University Medicine Greifswald

Completed

Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects (LOP-MNTX-2009)

Intestinal Obstruction

Germany
Woman's
AstraZeneca

Completed

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Obesity | Polycystic Ovary Syndrome

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); University of Southern California; University...

Completed

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

Cancer Free Women

United States
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Pain | Knee Osteoarthritis

Austria, Croatia, Germany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Slovakia, Spain, United Kingdom
Orexigen Therapeutics, Inc

Terminated

Naltrexone/Bupropion Cardiovascular Outcomes Study

Cardiovascular Diseases | Obesity

United States
Medical University of Vienna

Completed

Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters

Glomerular Filtration Rate | Fatty Acids, Nonesterified | Renal Circulation | Renal Plasma Flow

Austria
Matthew Neal MD
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE (ACTIV-4A)

Covid19

United States, Spain, Brazil, Italy
University of California, Davis

Completed

A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine

Chronic Pain

3

Subscribe